CD BioSciences, a comprehensive life science research company, is excited to announce the opening of its state-of-the-art Drosophila center. This new center is dedicated to the study and research of Drosophila melanogaster such as micro-injection, genome editing, cell engineering, genetics, metabolism, neurobiology, and other fields.

Drosophila is a genus of small flies commonly known as fruit flies. They are often used in scientific research as model organisms due to their short lifespan, rapid reproduction rate, and genetic similarity to humans. Drosophila has been instrumental in understanding genetics, development, behavior, and other biological processes. They are also commonly used in genetics laboratories for studies involving mutation, gene expression, and genetic manipulation.

To meet the increasing scientific needs for Drosophila-associated research, CD BioSciences integrates resources and expertise to establish the Drosophila center that is equipped with a complete Drosophila experimental platform to support research and experiments involving Drosophila. Besides, with an experienced Drosophila research team, CD BioSciences can provide global clients with both standard and innovative Drosophila research services including Drosophila genetic engineering services, RNAi services, phenotype analysis services, in vivo and in vitro imaging services, drug screening services, and many more.

In addition to Drosophila-based services, the Drosophila center also offers a comprehensive portfolio of Drosophila-related products including Drosophila consumables, Drosophila media, Drosophila strains, Drosophila antibodies, Drosophila cell lines, and recombinant Drosophila proteins. By providing high-quality Drosophila products, CD BioSciences is committed to enhancing the productivity and reproducibility of Drosophila-involved study, facilitating advances in a wide range of scientific projects.

The Drosophila center at CD BioSciences aims to provide researchers with the tools and resources they need to further advance their understanding of genetics and disease mechanisms. With the business expansion of CD BioSciences, the company continues to closely collaborate with academic institutions, biotech companies, and research organizations to foster innovation and discovery in the field of life sciences.

About CD BioSciences

CD BioSciences Drosophila Center is engaged in Drosophila research. With a mission to provide high-quality and affordable Drosophila products and services, CD BioSciences develops solutions by precise genetic modification of Drosophila as humanized models, as well as diverse phenotypes analysis for fundamental research and drug discovery. After years of development, its clients have spread throughout the world's biomedical academic institutions, biotechnology and pharmaceutical industries, clinical institutions, and government agencies.